Use of a novel human ULIP6/CRMP protein in diagnosis of paraneoplastic neurological syndromes
US7329499B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 28, 2001 |
| Grant date | Feb 12, 2008 |
| Priority date | — |
| Expiry date | Sep 26, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns a purified polypeptide, called ULIP6, comprising an amino acid sequence SEQ ID NO 2, the nucleic acid coding for said polypeptide, a non-coding sequence in 3′ of said encoding sequence and their use in diagnosis and treatment of cancers and paraneoplastic neurological syndromes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.